These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23925934)

  • 21. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.
    Weaver DJ; Liu B; Tisch R
    J Immunol; 2001 Jul; 167(1):586-92. PubMed ID: 11418698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice.
    Dong H; Huang Y; Yao S; Liang B; Long Y; Xie Y; Mai J; Gong S; Zhou Z
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5819-5829. PubMed ID: 28608279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis.
    Carter JE; Yu J; Choi NW; Hough J; Henderson D; He D; Langridge WH
    Mol Biotechnol; 2006 Jan; 32(1):1-15. PubMed ID: 16382177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes.
    Kobayashi M; Abiru N; Arakawa T; Fukushima K; Zhou H; Kawasaki E; Yamasaki H; Liu E; Miao D; Wong FS; Eisenbarth GS; Eguchi K
    J Immunol; 2007 Aug; 179(4):2082-8. PubMed ID: 17675466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
    Aspord C; Thivolet C
    Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo.
    Wilson SS; White TC; DeLuca D
    J Immunol; 2001 Jul; 167(1):569-77. PubMed ID: 11418696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.
    Gong Z; Long X; Pan L; Le Y; Liu Q; Wang S; Guo J; Xiao B; Zhou M; Mei D
    Protein Expr Purif; 2009 Aug; 66(2):191-7. PubMed ID: 19364533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
    Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
    You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
    J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
    Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
    J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
    Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
    Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
    Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
    J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
    Li L; Yi Z; Wang B; Tisch R
    J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.
    Ma S; Huang Y; Yin Z; Menassa R; Brandle JE; Jevnikar AM
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5680-5. PubMed ID: 15056761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
    Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
    J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.
    Denes B; Krausova V; Fodor N; Timiryasova T; Henderson D; Hough J; Yu J; Fodor I; Langridge WH
    J Immunother; 2005; 28(5):438-48. PubMed ID: 16113600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.